Yahoo Finance

Daré Bioscience's Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause

DARE-HRT1 is a novel, investigational intravaginal ring (IVR) designed to deliver bio-identical 17β-estradiol and bio-identical progesterone continuously over 28 days as part of a hormone therapy (HT) ...
Yahoo Finance

Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a ...

SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the publication of positive preliminary efficacy results from ...
Nasdaq

Daré Bioscience, Inc. and ARPA-H Ring the Closing Bell

Daré Bioscience Inc. (Nasdaq: DARE), a leader in innovation for the health and wellbeing of women, and the $4B federal health agency ARPA-H visit the Nasdaq MarketSite in Times Square. At the close of ...
FierceBiotech

Daré nabs implant tech, posts data for hormone-free contraceptive ring

Daré Bioscience is gathering steam—the women’s health player snapped up a microchip-based implant that could become a programmable, long-term contraceptive tool and unveiled positive data for its ...
WREG

Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a ...

DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen hormone therapy SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience ...